A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.

MLA

Ando, Midori, et al. “A20 (TNFAIP3) Deletion in Epstein-Barr Virus-Associated Lymphoproliferative Disorders/Lymphomas.” PloS One, vol. 8, no. 2, 2013, p. e56741. EBSCOhost, https://doi.org/10.1371/journal.pone.0056741.

APA

Ando, M., Sato, Y., Takata, K., Nomoto, J., Nakamura, S., Ohshima, K., Takeuchi, T., Orita, Y., Kobayashi, Y., & Yoshino, T. (2013). A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas. PloS One, 8(2), e56741. https://doi.org/10.1371/journal.pone.0056741

Chicago

Ando, Midori, Yasuharu Sato, Katsuyoshi Takata, Junko Nomoto, Shigeo Nakamura, Koichi Ohshima, Tamotsu Takeuchi, Yorihisa Orita, Yukio Kobayashi, and Tadashi Yoshino. 2013. “A20 (TNFAIP3) Deletion in Epstein-Barr Virus-Associated Lymphoproliferative Disorders/Lymphomas.” PloS One 8 (2): e56741. doi:10.1371/journal.pone.0056741.